Core Laboratories N.V. (CLB) Misses Q3 EPS by 9c; Guides Q4 EPS, Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St choppy as megacap losses offset chip gains before Fed decision
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- S&P Global explores potential separation of Capital IQ business
- SpaceX stock drops amid spaceport lawsuit, debt concerns
- Wall Street ends higher on revived AI momentum
- Nebius Group shares jump after France data center funding
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
HSBC Upgrades Core Laboratories (CLB) to Overweight
October 19, 2012 1:17 PM EDTHSBC upgraded Core Laboratories (NYSE: CLB) from Neutral to Overweight with a price target of $128.00 (from $129.00).
For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on... More



